109 related articles for article (PubMed ID: 9356988)
1. Molecular approaches to identifying ligand binding and signaling domains of C-C chemokine receptors.
Monteclaro FS; Arai H; Charo IF
Methods Enzymol; 1997; 288():70-84. PubMed ID: 9356988
[TBL] [Abstract][Full Text] [Related]
2. Chimeric chemokine receptors for analysis of structure-function relationships.
Peiper SC; Lu ZH; Zhang TY; Wang ZX
Methods Enzymol; 1997; 288():56-70. PubMed ID: 9356987
[No Abstract] [Full Text] [Related]
3. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.
de Mendonça FL; da Fonseca PC; Phillips RM; Saldanha JW; Williams TJ; Pease JE
J Biol Chem; 2005 Feb; 280(6):4808-16. PubMed ID: 15548526
[TBL] [Abstract][Full Text] [Related]
4. Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors.
Wang WW; Shahrestanifar M; Jin J; Howells RD
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12436-40. PubMed ID: 8618916
[TBL] [Abstract][Full Text] [Related]
5. C-X-C chemokine receptor desensitization mediated through ligand-enhanced receptor phosphorylation on serine residues.
Richmond A; Mueller S; White JR; Schraw W
Methods Enzymol; 1997; 288():3-15. PubMed ID: 9356983
[No Abstract] [Full Text] [Related]
6. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
Carter PH; Tebben AJ
Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
[TBL] [Abstract][Full Text] [Related]
7. Structural Analysis of Chemokine Receptor-Ligand Interactions.
Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C
J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of G-protein-mediated signaling by chemokine receptors.
Arai H; Charo IF
J Biol Chem; 1996 Sep; 271(36):21814-9. PubMed ID: 8702980
[TBL] [Abstract][Full Text] [Related]
9. Role of the first extracellular loop in the functional activation of CCR2. The first extracellular loop contains distinct domains necessary for both agonist binding and transmembrane signaling.
Han KH; Green SR; Tangirala RK; Tanaka S; Quehenberger O
J Biol Chem; 1999 Nov; 274(45):32055-62. PubMed ID: 10542238
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of CCR6: involvement of multiple domains in ligand binding and receptor signaling.
Ai LS; Lee SF; Chen SS; Liao F
J Biomed Sci; 2004; 11(6):818-28. PubMed ID: 15591779
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.
Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF
J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a rat macrophage inflammatory protein-1alpha receptor.
Waller A; Nayee P; Czaplewski LG
J Hematother Stem Cell Res; 2000 Oct; 9(5):703-9. PubMed ID: 11091494
[TBL] [Abstract][Full Text] [Related]
13. Identification of determinants in the alpha-subunit of Gq required for phospholipase C activation.
Venkatakrishnan G; Exton JH
J Biol Chem; 1996 Mar; 271(9):5066-72. PubMed ID: 8617784
[TBL] [Abstract][Full Text] [Related]
14. CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach.
Berkhout TA; Blaney FE; Bridges AM; Cooper DG; Forbes IT; Gribble AD; Groot PH; Hardy A; Ife RJ; Kaur R; Moores KE; Shillito H; Willetts J; Witherington J
J Med Chem; 2003 Sep; 46(19):4070-86. PubMed ID: 12954060
[TBL] [Abstract][Full Text] [Related]
15. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.
Hemmerich S; Paavola C; Bloom A; Bhakta S; Freedman R; Grunberger D; Krstenansky J; Lee S; McCarley D; Mulkins M; Wong B; Pease J; Mizoue L; Mirzadegan T; Polsky I; Thompson K; Handel TM; Jarnagin K
Biochemistry; 1999 Oct; 38(40):13013-25. PubMed ID: 10529171
[TBL] [Abstract][Full Text] [Related]
16. Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation.
Datta-Mannan A; Stone MJ
Biochemistry; 2004 Nov; 43(46):14602-11. PubMed ID: 15544331
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction by the chemokine receptor CXCR5: structural requirements for G protein activation analyzed by chimeric CXCR1/CXCR5 molecules.
Müller G; Lipp M
Biol Chem; 2001 Sep; 382(9):1387-97. PubMed ID: 11688722
[TBL] [Abstract][Full Text] [Related]
18. GluVII:06--a highly conserved and selective anchor point for non-peptide ligands in chemokine receptors.
Rosenkilde MM; Schwartz TW
Curr Top Med Chem; 2006; 6(13):1319-33. PubMed ID: 16918451
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions.
Gavrilin MA; Gulina IV; Kawano T; Dragan S; Chakravarti L; Kolattukudy PE
Biochem Biophys Res Commun; 2005 Feb; 327(2):533-40. PubMed ID: 15629146
[TBL] [Abstract][Full Text] [Related]
20. Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor.
Martín-Martínez M; Marty A; Jourdan M; Escrieut C; Archer E; González-Muñiz R; García-López MT; Maigret B; Herranz R; Fourmy D
J Med Chem; 2005 Jul; 48(15):4842-50. PubMed ID: 16033264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
